Statins provide no benefits, or adverse effects, in patients with lung cancer, according to a phase 3 trial.
Statins could be an effective agent for the treatment of patients with metastatic small cell lung cancer.
New guidelines released by the American College of Cardiology (ACC) and the American Heart Association (AHA) would have 13 million more Americans taking the cholesterol drugs, experts say.
Statin use may slow prostate cancer progression in patients receiving androgen deprivation therapy, but more trials are needed to confirm benefits, researchers say.
The use of statins for a year before a diagnosis of lung cancer is associated with a lower risk of cancer-specific mortality, but more research is needed.
Risk reduction appears sex specific, with significant reduction seen for men, but not women.
Findings among men taking a statin alongside androgen deprivation therapy showed additional months of progression-free survival.
Low density lipoprotein (LDL), or "bad cholesterol," stays the same or increases after taking statin medications.
Clinical trials on the use of statins as an anticancer drug have yielded mixed results.
Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
- Distress Management Tool Gets an Update, Patient Version
- PSA Screening Rates Level Off in United States
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|